Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DGX

Quest Diagnostics, Inc

Mar 21 • 04:00PM ET

167.11

Dollar change +0.65
Percentage change 0.39	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: LH NEO EXAS OPK NTRA PMD

| Held by: VTI VOO VO SPY IVV VTV RSP XLV VOE VIG

Scroll to Statements

Index	S&P 500	P/E	21.71	EPS (ttm)	7.70	Insider Own	0.56%	Shs Outstand	111.00M	Perf Week	-1.79%
Market Cap	18.55B	Forward P/E	15.87	EPS next Y	10.53	Insider Trans	-14.51%	Shs Float	110.35M	Perf Month	-2.92%
Income	866.00M	PEG	2.57	EPS next Q	2.17	Inst Own	91.43%	Short Float	2.32%	Perf Quarter	7.47%
Sales	9.87B	P/S	1.88	EPS this Y	8.50%	Inst Trans	1.48%	Short Ratio	2.43	Perf Half Y	7.48%
Book/sh	61.06	P/B	2.74	EPS next Y	8.67%	ROA	5.74%	Short Interest	2.57M	Perf Year	29.48%
Cash/sh	4.95	P/C	33.78	EPS next 5Y	8.45%	ROE	13.24%	52W Range	125.42 - 178.87	Perf YTD	10.77%
Dividend Est.	3.03 (1.82%)	P/FCF	20.40	EPS past 5Y	4.04%	ROI	6.70%	52W High	-6.57%	Beta	0.79
Dividend TTM	3.00 (1.80%)	Quick Ratio	1.02	Sales past 5Y	5.68%	Gross Margin	31.87%	52W Low	33.24%	ATR (14)	3.97
Dividend Ex-Date	Apr 07, 2025	Current Ratio	1.10	EPS Y/Y TTM	2.56%	Oper. Margin	14.31%	RSI (14)	46.44	Volatility	2.18% 2.23%
Employees	56000	Debt/Eq	1.05	Sales Y/Y TTM	6.70%	Profit Margin	8.77%	Recom	2.14	Target Price	179.73
Option/Short	Yes / Yes	LT Debt/Eq	0.91	EPS Q/Q	14.58%	Payout	39.15%	Rel Volume	1.36	Prev Close	166.46
Sales Surprise	1.65%	EPS Surprise	2.02%	Sales Q/Q	14.55%	Earnings	Jan 30 BMO	Avg Volume	1.06M	Price	167.11
SMA20	-2.64%	SMA50	1.33%	SMA200	8.25%	Trades		Volume	1,437,214	Change	0.39%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-04-25	Downgrade	Citigroup	Buy → Neutral	$185
Jan-06-25	Upgrade	Leerink Partners	Market Perform → Outperform	$169 → $174
Dec-17-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$145 → $172
Dec-10-24	Resumed	Jefferies	Buy	$175 → $185
Oct-23-24	Upgrade	Robert W. Baird	Neutral → Outperform	$157 → $182
Aug-28-24	Resumed	Evercore ISI	In-line	$165
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$145 → $165
Feb-26-24	Initiated	Leerink Partners	Market Perform	$135
Feb-07-24	Upgrade	Jefferies	Hold → Buy	$140 → $155
Jan-03-24	Initiated	Barclays	Equal Weight	$145
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$140 → $160
Jun-29-23	Initiated	Piper Sandler	Neutral
May-02-23	Downgrade	BofA Securities	Buy → Neutral	$166 → $148
Apr-03-23	Upgrade	Citigroup	Sell → Neutral	$125 → $142
Jan-23-23	Initiated	Evercore ISI	In-line	$159
Nov-17-22	Downgrade	Citigroup	Neutral → Sell	$145 → $125
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight	$142
Apr-04-22	Downgrade	Citigroup	Buy → Neutral	$175 → $140
Feb-23-22	Downgrade	UBS	Buy → Neutral	$160 → $139
Feb-02-22	Downgrade	Jefferies	Buy → Hold	$135

Show Previous Ratings

Mar-21-25 08:19AM	DGX Stock Set to Benefit From New Google Cloud Partnership (Zacks)
Mar-20-25 12:05PM	Autodesk in proxy fight, General Mills reports mixed Q3: Morning Buzz (TipRanks)
Mar-19-25 02:13PM	Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight (Zacks)
07:52AM	Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day (PR Newswire)
Mar-18-25 09:00AM	Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI (PR Newswire)
05:08AM	Loading…
Mar-14-25 05:08AM	Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX) (StockStory)
Feb-25-25 12:52PM	Fresenius Medical Care divests workforce by 8,200; sells Spectra assets (Medical Device Network)
Feb-24-25 11:21PM	Quest to buy Fresenius Medical Care kidney testing assets (MedTech Dive)
02:35PM	Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year (ACCESSWIRE)
08:00AM	Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics (PR Newswire)
Feb-21-25 02:15AM	GRAIL Inc (GRAL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
Feb-20-25 04:03AM	3 Reasons to Avoid DGX and 1 Stock to Buy Instead (StockStory)
Feb-19-25 04:12PM	Hims & Hers Health surges on acquisition for at-home testing (Yahoo Finance Video)
12:20PM	My Quest Story - Esmeralda Bonilla (ACCESSWIRE)
10:10AM	Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire)
04:54PM	Loading…
Feb-13-25 04:54PM	Quest Diagnostics to Host Investor Day on March 19, 2025 (PR Newswire)
03:30PM	My Quest Story - Manny Cetina (ACCESSWIRE)
10:07AM	Grail and Quest Diagnostics to offer Galleri test to US physicians (Medical Device Network)
Feb-12-25 05:57PM	Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts (Yahoo Finance)
12:50PM	Why Grail (GRAL) Stock Is Jumping Today (Insider Monkey)
09:00AM	GRAIL and Quest Diagnostics Provide GRAIL's Galleri Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System (PR Newswire)
Feb-10-25 09:50AM	Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-04-25 05:29PM	Quests (NYSE:DGX) Q4: Beats On Revenue (StockStory)
09:40AM	Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term (Zacks)
Feb-03-25 02:00PM	From College to Career - Experiencing the Building Blocks of Professional Success (ACCESSWIRE)
09:45AM	Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock (Zacks)
Jan-31-25 12:00PM	Quest Diagnostics (DGX) is a Great Momentum Stock: Should You Buy? (Zacks)
02:33AM	Quest Diagnostics Inc (DGX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
01:50AM	Q4 2024 Quest Diagnostics Inc Earnings Call (Thomson Reuters StreetEvents)
Jan-30-25 05:56PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research) +5.62%
04:14PM	Loading…
04:14PM	Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year (PR Newswire)
04:07PM	Why Quest Diagnostics Stock Was Blasting Higher Today (Motley Fool)
07:55AM	Quest Diagnostics (DGX) Q4 Earnings and Revenues Top Estimates (Zacks)
07:04AM	Quest Diagnostics: Q4 Earnings Snapshot (Associated Press Finance)
06:45AM	Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share (PR Newswire)
Jan-28-25 07:04AM	Quest Diagnostics completes University Hospitals asset acquisition (Hospital Management)
Jan-27-25 08:56AM	Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals (PR Newswire)
Jan-24-25 09:40AM	Should Value Investors Buy Quest Diagnostics (DGX) Stock? (Zacks)
Jan-08-25 01:45PM	My Quest Story - James Murphy, Jr. (ACCESSWIRE)
08:42AM	Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer (PR Newswire)
Jan-03-25 12:10PM	Why Quest Diagnostics (DGX) is Poised to Beat Earnings Estimates Again (Zacks)
Jan-02-25 11:15AM	Everyday Hero - Kris Constantino (ACCESSWIRE)
11:00AM	Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025 (PR Newswire)
Dec-23-24 12:30PM	Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management (ACCESSWIRE)
Dec-20-24 10:31AM	Mainz Biomed partners with Quest for colorectal cancer screening test (Medical Device Network)
Dec-19-24 08:01AM	Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test (GlobeNewswire)
Dec-17-24 03:10PM	Quest Diagnostics Advances Environmental Stewardship With Renewable Energy Initiatives, Waste Reduction, and ISO 14001 Certifications in 2023 (ACCESSWIRE)
Dec-03-24 09:50AM	Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference (PR Newswire)
08:23AM	Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health (PR Newswire)
Nov-28-24 05:30AM	Why Quest Diagnostics Incorporated (DGX) Is One of the Most Undervalued Pot Stocks to Buy? (Insider Monkey)
Nov-21-24 11:30AM	Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-20-24 02:44PM	Guardant Health Stock Sees RS Rating Jump To 83 (Investor's Business Daily)
Nov-13-24 12:00PM	All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy (Zacks)
Nov-12-24 05:57PM	Quest Diagnostics Declares Quarterly Cash Dividend (PR Newswire)
Oct-25-24 09:15AM	Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? (Zacks)
Oct-24-24 01:06AM	Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight (GuruFocus.com)
Oct-23-24 07:53AM	Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development (PR Newswire)
03:03AM	Quest Diagnostics Inc (DGX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
Oct-22-24 11:49PM	Q3 2024 Quest Diagnostics Inc Earnings Call (Thomson Reuters StreetEvents) +6.85%
05:22PM	S&P 500 Gains and Losses Today: GM Stock Pops as EVs and SUVs Drive Earnings Beat (Investopedia)
03:46PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
07:55AM	Quest Diagnostics (DGX) Beats Q3 Earnings and Revenue Estimates (Zacks)
06:51AM	Quest Diagnostics: Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024 (PR Newswire)
Oct-16-24 09:40AM	Are Investors Undervaluing Quest Diagnostics (DGX) Right Now? (Zacks)
Oct-15-24 10:00AM	Quest Diagnostics (DGX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:04AM	Quest Diagnostics Introduces Specimen Self-Collection for Common Genital Tract Infection Testing at Nationwide Network of Patient Service Centers (PR Newswire)
Oct-14-24 08:50AM	Quest Diagnostics Completes Acquisition of Lab Assets from OhioHealth (PR Newswire)
Sep-30-24 09:40AM	Is Quest Diagnostics (DGX) Stock Undervalued Right Now? (Zacks)
Sep-25-24 11:24AM	Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024 (PR Newswire)
Sep-24-24 09:40AM	Here's Why Quest Diagnostics (DGX) is a Strong Value Stock (Zacks)
Sep-18-24 08:51AM	Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast (PR Newswire)
Sep-16-24 08:51AM	Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health (PR Newswire)
Sep-05-24 09:40AM	Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term (Zacks)
Aug-30-24 09:40AM	Should Value Investors Buy Quest Diagnostics (DGX) Stock? (Zacks)
Aug-28-24 03:31PM	Quest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference (PR Newswire)
Aug-27-24 08:23AM	Quest Diagnostics completes LifeLabs acquisition from OMERS (Medical Device Network)
Aug-26-24 08:50AM	Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation (PR Newswire)
08:31AM	Quest Diagnostics' (DGX) New Deal Aids Diagnostic Access in Ohio (Zacks)
Aug-23-24 07:53AM	Quest inks deal for University Hospitals outreach lab services (MedTech Dive)
Aug-22-24 11:30AM	Quest Diagnostics (DGX) Up 6.3% Since Last Earnings Report: Can It Continue? (Zacks)
10:35AM	Quest Diagnostics to buy University Hospitals outreach lab assets (Hospital Management)
09:15AM	Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run? (Zacks)
Aug-21-24 08:55AM	Quest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business (PR Newswire)
Aug-19-24 08:07AM	Quest Diagnostics (DGX) Debuts Micronutrient Deficiency Panels (Zacks)
Aug-16-24 06:33AM	Universal DX secures funding to advance Signal-C blood test trial (Medical Device Network)
Aug-15-24 06:13PM	Quest Diagnostics Prices $1.85 Billion of Senior Notes (PR Newswire)
09:05AM	Quest Diagnostics' (DGX) New Study Exposes Alarming Data on STI (Zacks)
07:32AM	questhealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies (PR Newswire)
Aug-14-24 07:04PM	Quest Diagnostics Declares Quarterly Cash Dividend (PR Newswire)
09:40AM	Should Value Investors Buy Quest Diagnostics (DGX) Stock? (Zacks)
Aug-13-24 11:24AM	Quest Diagnostics (DGX) Gains From Innovation, Customer Wins (Zacks)
08:55AM	Should Quest Diagnostics (DGX) be in Your Portfolio Now? (Zacks)
Aug-12-24 08:51AM	Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends Study of Over 4 Million Pregnancies (PR Newswire)
Aug-11-24 07:37AM	The 'G' in ESG is gaining more shareholder love than the 'E' or 'S' (Yahoo Finance)
Aug-05-24 09:15AM	Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue? (Zacks)
Aug-01-24 06:48AM	Quest Diagnostics Named a 'Best Place to Work for Disability Inclusion' for Seventh Straight Year (PR Newswire)
Jul-29-24 09:40AM	Are Investors Undervaluing Quest Diagnostics (DGX) Right Now? (Zacks)
08:03AM	Haystack Oncology and Universit de Montral's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD Technology in Research Study for Metastatic Colorectal Cancer (PR Newswire)
Jul-26-24 01:04AM	Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight (GuruFocus.com)

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to physicians, hospitals, patients, and consumers. The All Other segment consists of risk assessment services and healthcare information technology. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PREVOZNIK MICHAEL E	SVP & General Counsel	Mar 17 '25	Sale	170.00	4,643	789,310	38,117	Mar 19 09:00 PM
PREVOZNIK MICHAEL E	Officer	Mar 17 '25	Proposed Sale	170.00	4,643	789,310		Mar 17 10:15 AM
Doherty Catherine T.	EVP, Regional Businesses	Mar 05 '25	Sale	174.13	5,370	935,078	68,068	Mar 07 07:23 PM
Doherty Catherine T.	EVP, Regional Businesses	Mar 04 '25	Sale	175.79	716	125,866	68,068	Mar 05 04:38 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Mar 04 '25	Sale	175.79	592	104,068	38,117	Mar 05 04:35 PM
Doherty Catherine T.	Officer	Mar 05 '25	Proposed Sale	174.13	5,370	935,078		Mar 05 09:59 AM
PREVOZNIK MICHAEL E	Officer	Mar 04 '25	Proposed Sale	175.79	592	104,068		Mar 04 10:20 AM
Doherty Catherine T.	Officer	Mar 04 '25	Proposed Sale	175.79	716	125,866		Mar 04 09:58 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 27 '25	Sale	172.61	528	91,138	39,031	Feb 28 04:38 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 27 '25	Sale	172.61	824	142,231	69,178	Feb 28 04:35 PM
Doherty Catherine T.	Officer	Feb 27 '25	Proposed Sale	172.61	824	142,231		Feb 27 10:52 AM
PREVOZNIK MICHAEL E	Officer	Feb 27 '25	Proposed Sale	172.61	528	91,138		Feb 27 10:41 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 20 '25	Sale	170.99	604	103,278	39,845	Feb 21 04:44 PM
Plewman Patrick	SVP for Diagnostic Services	Feb 19 '25	Sale	169.71	320	54,307	18,082	Feb 21 04:43 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 20 '25	Sale	170.99	899	153,720	70,457	Feb 21 04:41 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 19 '25	Sale	169.71	535	90,795	71,356	Feb 21 04:41 PM
PREVOZNIK MICHAEL E	Officer	Feb 20 '25	Proposed Sale	170.99	604	103,278		Feb 20 10:01 AM
Doherty Catherine T.	Officer	Feb 20 '25	Proposed Sale	170.99	899	153,720		Feb 20 09:56 AM
Gregg Vicky B	Director	Feb 05 '25	Sale	164.57	1,250	205,710	16,867	Feb 07 04:37 PM
DELANEY MARK E	SVP & Chief Commercial Officer	Feb 05 '25	Sale	164.30	403	66,214	4,624	Feb 07 04:36 PM
DELANEY MARK E	Officer	Feb 05 '25	Proposed Sale	164.30	403	66,214		Feb 05 05:06 PM
Gregg Vicky B	Director	Feb 05 '25	Proposed Sale	164.57	1,250	205,710		Feb 05 04:00 PM
DELANEY MARK E	Officer	Jan 31 '25	Proposed Sale	164.85	2,615	431,094		Jan 31 01:12 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Nov 29 '24	Option Exercise	86.63	35,146	3,044,698	73,624	Dec 02 04:43 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Nov 29 '24	Sale	163.07	35,146	5,731,302	38,478	Dec 02 04:43 PM
Doherty Catherine T.	EVP, Regional Businesses	Nov 27 '24	Option Exercise	103.57	33,103	3,428,478	101,515	Dec 02 04:41 PM
Doherty Catherine T.	EVP, Regional Businesses	Nov 27 '24	Sale	162.99	33,103	5,395,484	68,412	Dec 02 04:41 PM
PREVOZNIK MICHAEL E	Officer	Nov 29 '24	Proposed Sale	163.07	35,146	5,731,302		Nov 29 02:42 PM
Doherty Catherine T.	Officer	Nov 27 '24	Proposed Sale	162.99	33,103	5,395,484		Nov 27 04:12 PM
DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Nov 06 '24	Option Exercise	68.66	18,755	1,287,634	53,696	Nov 07 05:21 PM
DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Nov 06 '24	Sale	154.05	18,755	2,889,123	34,941	Nov 07 05:21 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Oct 28 '24	Sale	156.92	1,775	278,525	9,734	Oct 30 04:26 PM
KUPPUSAMY KARTHIK	Officer	Oct 28 '24	Proposed Sale	156.87	1,775	278,450		Oct 28 12:51 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Aug 29 '24	Option Exercise	95.80	32,551	3,118,223	71,029	Sep 03 04:30 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Aug 29 '24	Sale	154.97	32,551	5,044,516	38,478	Sep 03 04:30 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Aug 28 '24	Sale	153.26	1,990	304,990	11,459	Aug 29 04:45 PM
PREVOZNIK MICHAEL E	Officer	Aug 29 '24	Proposed Sale	154.97	32,551	5,044,516		Aug 29 01:55 PM
KUPPUSAMY KARTHIK	Officer	Aug 28 '24	Proposed Sale	153.26	1,990	304,990		Aug 28 04:49 PM
DELANEY MARK E	SVP & Chief Commercial Officer	Jul 24 '24	Sale	143.08	420	60,094	5,019	Jul 26 06:33 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Apr 29 '24	Sale	140.00	1,760	246,400	13,435	May 01 04:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DGX

Quest Diagnostics, Inc

Upgrade your FINVIZ experience